03:39 PM EDT, 09/17/2024 (MT Newswires) -- Health care stocks were falling late Tuesday afternoon with the NYSE Health Care Index dropping 1.4% and the Health Care Select Sector SPDR Fund (XLV) retreating 1.2%.

The iShares Biotechnology ETF (IBB) eased 0.3%.

In corporate news, Novo Nordisk's ( NVO ) Ozempic is "very likely" to be one of the next drugs to face price negotiations with the US government, a company executive said Tuesday at the Cantor Global Healthcare Conference in New York, Bloomberg reported. Novo shares were falling 3.3%.